DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%
Clinical trial NCT01342081 · COMPLETED
Trial details
- NCT number
- NCT01342081
- Sponsor
- Santen Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-09-01
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.